Insulin Aspart (Genetical Recombination) The Japanese Pharmacopoeia



Insulin Aspart (Genetical Recombination) is a recombinant human insulin analogue, in which proline residue at 28th of B chain is substituted with aspartic acid. It is a peptide composed of A chain consisting of 21 amino acid residues and B chain consisting of 30 amino acid residues. It contains not less than 92.6% and not more than 109.5% of insulin aspart (genetical recombination)(C₂₅₆H₃₈₁N₆₅O₇₉S₆), calculated on the dried and residue on ignition-free basis. 0.0350 mg of Insulin Aspart (Genetical Recombination) is equivalent to 1 Insulin Unit.

[116094-23-6]